The KNDS IPO Was Suspended, Not Canceled - And That's Exactly What Makes It Interesting

The competitor headline says Germany and France are weighing "full state control" of tank maker KNDS. That framing is wrong on the mechanics and misleading on the investment implication.

The actual deal is not nationalization. France is reducing its stake from 50% to 40%. Germany is stepping in at a matching 40%. That leaves 20% of the company floating on the Paris and Frankfurt exchanges. The two governments hold equal governance rights and a long-term shareholder commitment, but this is a partially public company with an institutional shareholder base, not a state enterprise locked in a vault.

More importantly, the IPO was announced on June 24 and suspended in early July after the NATO Summit. As of today, the shares are not trading. The market context around that suspension is where the real story lives - and where the risk/reward calculation actually sits.

The order book tells the first story

KNDS reported €4.4 billion in revenue for 2025. That's up from the run-rate the company was on two years ago, when the Ukraine war was still in its early procurement cycle. The earnings before interest, taxes, and amortization came in at €661 million - healthy margins for a land-systems manufacturer.

But the number that matters most is the order backlog: €33.1 billion as of December 31, 2025. That is nearly eight years of current revenue sitting in the queue. For a company whose medium-term revenue target is €11–12 billion, the backlog provides visibility most defense primes would kill for.

The products behind that backlog are the Leopard 2 main battle tank (and its Stridsvagn 123 variant, which just delivered 110 modernized units to Sweden in June), the Leclerc, the Boxer armoured fighting vehicle, and a broad range of infantry fighting vehicles, artillery, and unmanned ground systems. KNDS doesn't sell consumer electronics. It sells platforms that armies cannot function without, and it takes years to build them. That's not a moat you cross on a whim.

Pricing power in defense is different - and the question is execution, not demand

When I talk about pricing power, the usual test is whether a company can raise prices without losing customers. In defense, the dynamic is inverted. The customers are governments, and the pricing is shaped by procurement frameworks, multi-year contracts, and industrial policy. You don't "raise prices" in the consumer sense. What you do have - if you're structurally positioned - is inelastic demand. An army that has ordered 3,000 Boxer vehicles or committed to a Leopard 2 modernization program isn't canceling because of a bad quarter.

KNDS passes the pricing power test in that sense. The demand is mission-critical. The real question for investors is execution capacity. Can the company actually scale production from €4.4 billion to €11–12 billion without margin compression from labor shortages, supply chain bottlenecks, or cost overruns? That's the risk the backlog hides.

The IPO timing was terrible

Here's the thing: the IPO was announced on June 24 and suspended less than two weeks later. The European defense sector had just entered a sharp pullback, and it hasn't recovered.

Rheinmetall - Europe's largest ammunition maker and KNDS's closest German peer in land systems - was down roughly a quarter of its value by mid-2026. The selloff accelerated after Germany scrapped the F126 frigate program, wiping out what would have been the country's largest naval commission since the Second World War. Rheinmetall was the expected lead contractor. The stock plunged more than 13% in a single session, then another 18% in the days that followed.

The broader picture is worse. Morningstar's chief equity strategist Michael Field put it bluntly ahead of the IPO announcement: "It's a pretty good time to be investing in defense. I'm not sure it's a great time to be IPO-ing."

European defense stocks had been riding a years-long rally built on government pledges of hundreds of billions of euros in new military spending. But investors began questioning whether those promises would translate into earnings growth quickly enough. The sector was already vulnerable. Then Germany's procurement politics delivered the knockout.

SIPRI confirms the structural trend - but the market doesn't care about 2025 data

The Stockholm International Peace Research Institute reported that European military spending surged 14% in 2025 to $864 billion. NATO's 29 European members spent a combined $559 billion. Germany alone jumped 24% to $114 billion, exceeding the 2% of GDP threshold for the first time since 1990.

That's the structural thesis. It's the secular tailwind that makes defense a real-economy sector in a deglobalizing world. But structural trends don't protect you from quarterly disappointment, political reversals, or IPO windows that close.

Germany scrapping the F126 program proves the other side of the coin: government procurement is political. Orders can be announced with fanfare and canceled six months later. That's the risk defense investors have to price in.

What the valuation tells us

Before the IPO was suspended, reported valuations ranged from €12–15 billion (Financial Times) to €15–18 billion (Reuters and Bloomberg). Let's work through what that means.

At €15 billion and €661 million of 2025 EBITA, the implied multiple is roughly 22.7x earnings. At the top of the range, €18 billion, it's 27.2x. For context, that's premium territory for a company whose revenue is still relatively small and whose execution at scale hasn't been proven. These multiples make sense only if the €33.1 billion backlog converts to earnings faster than skeptics expect and margins hold as the company scales toward €11–12 billion in revenue.

If the IPO reopens at the lower end of that range, or below it - which is possible given the sector pullback - the risk/reward improves. The backlog provides a floor. The multiple at the low end would be more defensible.

The state ownership structure is actually a feature, not a bug

I don't think the 80% government ownership is the bear case that some readers assume. In defense, having sovereign customers as committed long-term shareholders reduces the risk of hostile takeovers, short-term earnings pressure, and the kind of activist interventions that can derail multi-year industrial programs. The Franco-German framework explicitly commits to long-term shareholding and parity in governance.

What this does create, though, is a concentrated float. Only 20% of the company trades on the open market. Liquidity could be thin. Price moves could be volatile. Institutional buyers will dominate the shareholder base, since the IPO was structured as a direct placement with no retail offering.

The counterargument: political risk is the real moat - and it cuts both ways

The strongest case against investing in KNDS right now is simple: the company's biggest customers are the same governments that own most of its shares. When Berlin cancels a procurement program (F126), or when Paris shifts industrial priorities, the company's revenue outlook changes regardless of how large the backlog looks today.

This is the mirror image of the pricing power thesis. Inelastic demand from sovereign customers is great when the orders flow - but sovereign customers can change their minds, delay payments, or redirect funding. That's why Rheinmetall got hit so hard by the F126 cancellation. The same political force that protects KNDS's order book can also undermine it.

What I'm watching

The KNDS IPO suspension is a pause, not a cancellation. The structural case - the €33.1 billion backlog, the Leopard and Boxer programs that European armies need, the 14% surge in European military spending - hasn't changed. The near-term case - sector sentiment, valuation, IPO timing, and political risk in procurement - has gotten harder.

I believe defense is a real-economy sector that benefits from deglobalization, rearmament, and the kind of structurally higher inflation that makes tangible industrial capacity more valuable than abstract financial claims. KNDS fits that thesis. But the IPO suspended in the worst possible window, at a valuation that already assumes rapid backlog conversion, in a sector that's selling off.

I don't think this is the kind of setup where you need to rush in. If the IPO reopens and the market prices it toward the lower end of the reported range, the risk/reward becomes interesting. The backlog provides visibility. The sovereign shareholders provide stability. The production capacity is real.

If it reopens at the top of the range, after a sector that's down 25% year-to-date, I'd let someone else pay that premium. Even the best TOLL stock - one that charges tolls on things the economy can't function without - is a bad investment at the wrong price.

The equity yield curve teaches us that the best entries come when quality businesses are temporarily out of favor. KNDS might be building toward that moment. The question is whether the IPO timetable will wait for it.